Dr. Agarwal's Health Care Share Price
513.85+2.40 (+0.47%)
+21.85% past 1 Year
Dr. Agarwal's Health Care provides a comprehensive range of eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sell opticals, contact lens and accessories,
Corporate filings & documents
Announcements
Newspaper Advertisement - Sixteenth Annual General Meeting of Dr. Agarwals Health Care Limited Instructions for e-Voting and Other Related Information is submitted.
5 days agoNewspaper Advertisement - Sixteenth Annual General Meeting of Dr. Agarwals Health Care Limited Instructions for e-Voting and Other Related Information is submitted.
5 days agoAnnual Report of the Company for the Financial Year 2025-26 is submitted.
6 days agoAnnual Report of the Company for the Financial Year 2025-26 is submitted.
6 days agoNotice convening the Sixteenth AGM of the Company on September 21 2026 along with the Annual Report for the financial year 2025-26 is submitted.
6 days agoNotice convening the Sixteenth AGM of the Company on September 21 2026 along with the Annual Report for the financial year 2025-26 is submitted.
6 days agoMedia Release - Launch of Worlds First Pinhole Pupilloplasty (PPP) Centre by Dr. Agarwals Eye Hospital Limited a subsidiary of the Company is submitted
1 week agoMedia Release - Launch of Worlds First Pinhole Pupilloplasty (PPP) Centre by Dr. Agarwals Eye Hospital Limited a subsidiary of the Company is submitted
1 week agoIntimation of Schedule of Analyst / Investors Meet is submitted.
1 week agoIntimation of Schedule of Analyst / Investors Meet is submitted.
1 week agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Catalyst Trusteeship Ltd
1 week agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Catalyst Trusteeship Ltd
1 week agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for DB International Trust (Singapore) Ltd
2 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for DB International Trust (Singapore) Ltd
2 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Claymore Investments (Mauritius) Pte Ltd
3 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Claymore Investments (Mauritius) Pte Ltd
3 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Hyperion Investments Pte Ltd
3 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Hyperion Investments Pte Ltd
3 weeks agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Invesco Mutual Fund
3 weeks agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Invesco Mutual Fund
3 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Catalyst Trusteeship Ltd
3 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Catalyst Trusteeship Ltd
3 weeks agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for ICICI Prudential Mutual Fund
3 weeks agoThe Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for ICICI Prudential Mutual Fund
3 weeks agoTranscript of the discussion held on the Unaudited Financial Results (Consolidated & Standalone) of the Company for the quarter ended June 30 2026 at the analyst call held on August 04 2026 is attached.
3 weeks agoTranscript of the discussion held on the Unaudited Financial Results (Consolidated & Standalone) of the Company for the quarter ended June 30 2026 at the analyst call held on August 04 2026 is attached.
3 weeks agoLink for the Audio recording of the Analyst / Earnings Conference call held on the Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter ended June 30 2025 at the analyst meet held on August 04 2026 is available on the website of the Company.
1 month agoLink for the Audio recording of the Analyst / Earnings Conference call held on the Unaudited Financial Results (Consolidated and Standalone) of the Company for the quarter ended June 30 2025 at the analyst meet held on August 04 2026 is available on the website of the Company.
1 month agoDr. Agarwals Health Care Limited - Monitoring Agency Report for the quarter ended June 30 2026 is submitted.
1 month agoDr. Agarwals Health Care Limited - Monitoring Agency Report for the quarter ended June 30 2026 is submitted.
1 month agoPresentation on the Unaudited Financial Results (Consolidated & Standalone) of the Company for the quarter ended June 30 2026 is attached.
1 month agoPresentation on the Unaudited Financial Results (Consolidated & Standalone) of the Company for the quarter ended June 30 2026 is attached.
1 month agoConsolidated and Standalone Unaudited Financial Results of the Company for the quarter ended June 30 2026 is submitted.
1 month agoConsolidated and Standalone Unaudited Financial Results of the Company for the quarter ended June 30 2026 is submitted.
1 month agoOutcome of the Meeting of the Board of Directors of the Company held on August 04 2026 is attached.
1 month agoOutcome of the Meeting of the Board of Directors of the Company held on August 04 2026 is attached.
1 month agoIntimation of Analyst / Earnings Conference call to discuss the Unaudited Financial Results (Standalone & Consolidated) of the Company For The Quarter Ended June 30 2026 is attached
1 month agoIntimation of Analyst / Earnings Conference call to discuss the Unaudited Financial Results (Standalone & Consolidated) of the Company For The Quarter Ended June 30 2026 is attached
1 month agoDr. Agarwals Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026.
1 month agoDr. Agarwals Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026.
1 month agoNewspaper Advertisement of Notice of Hearing of the Companys Petition in relation to the Scheme of Amalgamation between Dr. Agarwals Eye Hospital Limited and Dr. Agarwals Health Care Limited is enclosed.
1 month agoNewspaper Advertisement of Notice of Hearing of the Companys Petition in relation to the Scheme of Amalgamation between Dr. Agarwals Eye Hospital Limited and Dr. Agarwals Health Care Limited is enclosed.
1 month agoAllotment of 43 155 Equity Shares pursuant to the exercise of options granted under Dr. Agarwals Health Care Limited - Employee Stock Option Scheme 2022.
1 month agoAllotment of 43 155 Equity Shares pursuant to the exercise of options granted under Dr. Agarwals Health Care Limited - Employee Stock Option Scheme 2022.
1 month agoCertificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended June 30 2026 is enclosed.
1 month agoCertificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended June 30 2026 is enclosed.
1 month agoVoting Results and the Consolidated Scrutinizers Report on the Honble NCLT convened meeting of the unsecured creditors of Dr. Agarwals Health Care Limited held on July 02 2026 is enclosed.
2 months agoSummary of the Proceedings of the Honble NCLT convened meeting of the Unsecured Creditors of Dr. Agarwals Health Care Limited held on July 02 2026 is enclosed.
2 months agoVoting Results and the Consolidated Scrutinizers Report on the Honble NCLT convened meeting of the Equity Shareholders of Dr. Agarwals Health Care Limited held on July 02 2026 is enclosed.
2 months agoSummary of the Proceedings of the Honble NCLT convened meeting of the Secured Creditors of Dr. Agarwals Health Care Limited held on July 02 2026 is enclosed.
2 months agoAnnual reports
Concalls & investor presentations
Aug 2026
May 2026
Feb 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Oct 2025
ConcallPresentation
Aug 2025
May 2025
ConcallPresentation
Feb 2025
ConcallPresentation
Feb 2025
ConcallPresentation
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
6th Floor, Menon Eternity 1st Main Road, Austin Nagar Alwarpet Chennai Tamil Nadu PIN: 600018 Tel No: 044-43787777 Fax No: NULL Email: [email protected] Internet: www.dragarwals.co.in
Registrars
Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001 Karvy Selenium Tower B, Plot 31-32 Gachibowli,Financial District Nanakramguda PIN: Tel No: 040 - 67162222/18003094001 Fax No: NULL Email: [email protected] Internet: www.kfintech.com
Management
Thanikainathan Arumugam, Company Secretary & Compliance Officer, VP – Corporate Affairs
Amar Agarwal, Chairman
Adil Agarwal, Whole Time Director & Chief Executive Officer
Anosh Agarwal, Whole Time Director & COO
Ranjan Ramdas Pai, Non Executive Independent Director
Nachiket Madhusudan Mor, Non Executive Independent Director
Venkatraman Balakrishnan, Non Executive Independent Director
Archana Bhaskar, Non Executive Independent Director
Sanjay Anand, Non Executive Independent Director
Ankur Nand Thadani, Non Independent & Non Executive Director
Details
BSE 544350
NSE AGARWALEYE
ISIN INE943P01029